Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
SKYE
$3.75
+11.61%
Analyze
1M
+10.0%
3M
+76.9%
1Y
-39.4%
Market Cap:
$116.21M
Skye Bioscience, Inc.
Healthcare | Biotechnology
Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes therapeutic drugs that modulate the endocannabinoid system. The company is headquartered in San Diego, California.
Click "Analyze" to generate stock analysis
SKYE Price Trend and Signals
SKYE Option Volumes & Open Interests (aggregated)
SKYE Put Call Ratios and IV (aggregated)
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-09-04
Bullish
macd_signal
Golden cross below zero detected.
2025-09-03
Bearish
macd_signal
Dead cross below zero detected.
2025-08-26
Bullish
macd_signal
Golden cross below zero detected.